S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)

Intelligent Bio Solutions (INBS) Earnings Date, Estimates & Call Transcripts

$0.30
-0.01 (-3.23%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.28
$0.32
50-Day Range
$0.21
$1.05
52-Week Range
$0.20
$32.00
Volume
659,032 shs
Average Volume
1.82 million shs
Market Capitalization
$2.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Earnings Summary

Upcoming
Earnings Date
Feb. 13Estimated
Actual EPS
(Nov. 8)
-$1.04 Missed By -$1.04
Skip Charts & View Estimated and Actual Earnings Data

INBS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INBS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Intelligent Bio Solutions Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20231($1.66)($1.66)($1.66)
20231($1.66)($1.66)($1.66)
Q2 20241($0.27)($0.27)($0.27)
Q3 20241($0.21)($0.21)($0.21)
Q4 20241($0.16)($0.16)($0.16)

INBS Earnings Date and Information

Intelligent Bio Solutions last released its quarterly earnings results on November 8th, 2023. The reported ($1.04) earnings per share for the quarter. The company earned $0.80 million during the quarter. Intelligent Bio Solutions has generated ($9.13) earnings per share over the last year (($9.13) diluted earnings per share). Earnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($1.67) to ($0.47) per share. Intelligent Bio Solutions has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 13th, 2024 based off prior year's report dates.

Intelligent Bio Solutions Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/13/2024
Estimated)
------- 
11/8/2023Q1 2024-($1.04)($1.04)($1.04)-$0.80 million
8/24/2023Q4 2023($1.66)($1.91)($0.25)($1.91)$0.49 million$0.44 million
5/11/2023Q3 2023-($2.03)($2.03)$1.66-$0.46 million
2/14/2023Q2 2023-($0.46)($0.46)($0.46)-$0.63 million
8/31/2022Q4 2022($3.60)($2.80)+$0.80($0.14)-$0.07 million
5/10/2022Q3 2022($3.20)($1.80)+$1.40($0.09)-$0.19 million
2/10/2022Q2 2022($3.20)($4.60)($1.40)($0.23)-$0.18 million
11/11/2021Q1 2022-($2.00)($2.00)($0.10)--
5/14/2021Q3 2021-($5.40)($5.40)($0.27)-$0.03 million
2/16/2021Q2 2021-($4.60)($4.60)($0.23)-$0.28 million












Intelligent Bio Solutions Earnings - Frequently Asked Questions

When is Intelligent Bio Solutions's earnings date?

Intelligent Bio Solutions has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 13th, 2024 based off last year's report dates. Learn more on INBS's earnings history.

How much revenue does Intelligent Bio Solutions generate each year?

Intelligent Bio Solutions (NASDAQ:INBS) has a recorded annual revenue of $2.05 million.

How much profit does Intelligent Bio Solutions generate each year?

Intelligent Bio Solutions (NASDAQ:INBS) has a recorded net income of -$10.63 million. INBS has generated -$9.13 earnings per share over the last four quarters.

What is Intelligent Bio Solutions's EPS forecast for next year?

Intelligent Bio Solutions's earnings are expected to grow from ($1.67) per share to ($0.47) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:INBS) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -